TrialThe lancet. Gastroenterology & hepatology2025

Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study.

Ujjwal M Mahajan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.